Cord Blood America, a company which is focused on brining the life saving potential of stem cells to families internationally, announced that the family of the Chief Executive Officer has loaned the company $223,500 to reduce its debt.
Matthew Schissler, CEO of Cord Blood America, stated, “Putting money into the Company provides it the short term working capital it needs, something that doesn’t occur if this discretionary money were spent instead on purchasing stock on the open market. This investment gives us the opportunity to focus on the long term growth.”
Let us hear your thoughts below: